Stock Events

Stock Events

Ultragenyx Pharmaceutical (RARE) Q2 2026 Earnings

5MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-1.84

-1.59

-1.34

-1.09

Details

Expected EPS

-1.487806

Actual EPS

-1.84

Surprise EPS

-0.35

Surprise Percent

+23.67%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.84 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.